Disruptive Pharma Operations AB
559174-6085ActiveTransforming oral drugs via proprietary bioavailability enhancement technology.
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 2018
- Grundlagt
Nøglebeslutningstagere
Stefan Ström
CFO
Peter Åsberg
CEO
Alexander Oker-Blom
Non-Executive Member of the Board
Marie Ehrling
Chairman
+17 flere kontakter i Funnelfeedr
Beskrivelse
Disruptive Pharma is an innovative, clinical-stage pharmaceutical development company based in Sweden. Their core mission is transforming drugs with poor oral bioavailability into effective, patient-friendly oral solid dosage forms. They achieve this using their proprietary technology platform calle...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559174608501
Beslutningstagere
21 kontakter i FunnelfeedrStefan Ström
CFO
Peter Åsberg
CEO
Alexander Oker-Blom
Non-Executive Member of the Board
Marie Ehrling
Chairman
Johan Bygge
Chairman of the Board
Tobias Agervald
Non-Executive Member of the Board
Marc Willuhn
Process Development Director
Karin Botha
CFO
Sven Undeland
Commercial Director
David Bejker
Non-Executive Member of the Board
Gunilla Ekström
Non-Executive Member of the Board
Maria Strömme
Board Member and Founder
Martina Ferneman
Commercial Director (consultant)
Sofia Mogensen
R&D Director and Project Management (consultant)
Göran Forsberg
Non-Executive Member of the Board
Malin Vågerö
Director of R&D
Tobias Assander
Manufacturing and Process Development Lead
Andre kontakter
Andreas Fischer
Senior Product Development Scientist
Matilda Engman
Scientist
Hans Thor
Senior Analytical Chemist
Evelina Meurling
Senior Formulation Scientist
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrVeltio Pharma AB
3 medarbejdereProprietary platform enhances poorly soluble drug bioavailability using cellulose.
Ribocure Pharmaceuticals AB
20–49 medarbejdereClinical stage biotech developing cutting-edge RNA therapeutics for rare diseases.
NANOFORM FINLAND OY
1–4 medarbejdereNanoforming technology enhances drug performance across development stages.
Extem Pharma AB
2 medarbejdereInnovative pharmaceutical startup specializing in 3D-printed, custom medications.
Double Bond Pharmaceutical AB
5–9 medarbejdereDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
Udforsk mere
Spørgsmål om Disruptive Pharma Operations AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo